The Minnesota Partnership for Biotechnology and Medical Genomics said it launched five projects researching diabetes, cancer, heart disease and reversing neurological damage from diseases such as Alzheimer's.
The partnership said it will use more than $3.5 million in state-funded grants for the projects.
The partnership is a collaboration between the state, University of Minnesota and Mayo Clinic.
"The projects being funded this year represent some of the best science anywhere, and encompass innovative approaches to some of the most important health issues in Minnesota," said Tucker LeBien, partnership director for the University of Minnesota. "The research performed by these teams could ultimately impact the lives of many Minnesotans and citizens beyond our borders."
